MY SIZE INC (MYSZ) Stock Fundamental Analysis

NASDAQ:MYSZ • US62844N4060

0.54 USD
-0.03 (-5.26%)
Last: Feb 13, 2026, 03:46 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to MYSZ. MYSZ was compared to 277 industry peers in the Software industry. Both the profitability and financial health of MYSZ have multiple concerns. While showing a medium growth rate, MYSZ is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year MYSZ has reported negative net income.
  • In the past year MYSZ has reported a negative cash flow from operations.
  • MYSZ had negative earnings in each of the past 5 years.
  • In the past 5 years MYSZ always reported negative operating cash flow.
MYSZ Yearly Net Income VS EBIT VS OCF VS FCFMYSZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

  • MYSZ has a Return On Assets of -29.75%. This is in the lower half of the industry: MYSZ underperforms 77.98% of its industry peers.
  • MYSZ has a Return On Equity of -48.90%. This is in the lower half of the industry: MYSZ underperforms 70.40% of its industry peers.
Industry RankSector Rank
ROA -29.75%
ROE -48.9%
ROIC N/A
ROA(3y)-65.46%
ROA(5y)-90.56%
ROE(3y)-125.28%
ROE(5y)-153.86%
ROIC(3y)N/A
ROIC(5y)N/A
MYSZ Yearly ROA, ROE, ROICMYSZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400 -400 600

1.3 Margins

  • MYSZ's Gross Margin of 38.67% is on the low side compared to the rest of the industry. MYSZ is outperformed by 77.98% of its industry peers.
  • MYSZ's Gross Margin has declined in the last couple of years.
  • MYSZ does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 38.67%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-26.17%
GM growth 5Y-9.6%
MYSZ Yearly Profit, Operating, Gross MarginsMYSZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • MYSZ does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • MYSZ has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, MYSZ has more shares outstanding
  • Compared to 1 year ago, MYSZ has an improved debt to assets ratio.
MYSZ Yearly Shares OutstandingMYSZ Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M
MYSZ Yearly Total Debt VS Total AssetsMYSZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

  • Based on the Altman-Z score of -7.29, we must say that MYSZ is in the distress zone and has some risk of bankruptcy.
  • MYSZ has a Altman-Z score of -7.29. This is amonst the worse of the industry: MYSZ underperforms 86.64% of its industry peers.
  • MYSZ has a Debt/Equity ratio of 0.13. This is a healthy value indicating a solid balance between debt and equity.
  • MYSZ's Debt to Equity ratio of 0.13 is in line compared to the rest of the industry. MYSZ outperforms 50.18% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Altman-Z -7.29
ROIC/WACCN/A
WACC10.32%
MYSZ Yearly LT Debt VS Equity VS FCFMYSZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M

2.3 Liquidity

  • MYSZ has a Current Ratio of 2.73. This indicates that MYSZ is financially healthy and has no problem in meeting its short term obligations.
  • MYSZ has a better Current ratio (2.73) than 72.92% of its industry peers.
  • MYSZ has a Quick Ratio of 1.72. This is a normal value and indicates that MYSZ is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of MYSZ (1.72) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.73
Quick Ratio 1.72
MYSZ Yearly Current Assets VS Current LiabilitesMYSZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 78.84% over the past year.
  • The Revenue for MYSZ has decreased by -22.01% in the past year. This is quite bad
  • MYSZ shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 165.15% yearly.
EPS 1Y (TTM)78.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%68%
Revenue 1Y (TTM)-22.01%
Revenue growth 3Y297.97%
Revenue growth 5Y165.15%
Sales Q2Q%39.86%

3.2 Future

  • Based on estimates for the next years, MYSZ will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.40% on average per year.
  • The Revenue is expected to grow by 18.22% on average over the next years. This is quite good.
EPS Next Y37.13%
EPS Next 2Y15.4%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.74%
Revenue Next 2Y18.22%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
MYSZ Yearly Revenue VS EstimatesMYSZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2M 4M 6M 8M 10M
MYSZ Yearly EPS VS EstimatesMYSZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2023 2024 2025 2026 -100 -200 -300

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • MYSZ reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MYSZ. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MYSZ Price Earnings VS Forward Price EarningsMYSZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MYSZ Per share dataMYSZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 -2

4.3 Compensation for Growth

  • A more expensive valuation may be justified as MYSZ's earnings are expected to grow with 15.40% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.4%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for MYSZ!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MY SIZE INC

NASDAQ:MYSZ (2/13/2026, 3:46:38 PM)

0.54

-0.03 (-5.26%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)03-27
Earnings (Next)N/A
Inst Owners3.26%
Inst Owner Change-11.76%
Ins Owners14.86%
Ins Owner Change13.7%
Market Cap2.08M
Revenue(TTM)7.51M
Net Income(TTM)-3.57M
Analysts82.86
Price Target3.06 (466.67%)
Short Float %6.56%
Short Ratio0.89
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)5.93%
EPS NY rev (3m)5.93%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-8.98%
Revenue NY rev (3m)-8.98%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.28
P/FCF N/A
P/OCF N/A
P/B 0.27
P/tB 0.4
EV/EBITDA N/A
EPS(TTM)-1.61
EYN/A
EPS(NY)-2.75
Fwd EYN/A
FCF(TTM)-0.89
FCFYN/A
OCF(TTM)-0.88
OCFYN/A
SpS1.95
BVpS1.98
TBVpS1.35
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -29.75%
ROE -48.9%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 38.67%
FCFM N/A
ROA(3y)-65.46%
ROA(5y)-90.56%
ROE(3y)-125.28%
ROE(5y)-153.86%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-26.17%
GM growth 5Y-9.6%
F-Score3
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.73
Quick Ratio 1.72
Altman-Z -7.29
F-Score3
WACC10.32%
ROIC/WACCN/A
Cap/Depr(3y)6.43%
Cap/Depr(5y)22.81%
Cap/Sales(3y)0.28%
Cap/Sales(5y)5.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)78.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%68%
EPS Next Y37.13%
EPS Next 2Y15.4%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-22.01%
Revenue growth 3Y297.97%
Revenue growth 5Y165.15%
Sales Q2Q%39.86%
Revenue Next Year2.74%
Revenue Next 2Y18.22%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-0.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y46.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y46.7%
OCF growth 3YN/A
OCF growth 5YN/A

MY SIZE INC / MYSZ FAQ

What is the fundamental rating for MYSZ stock?

ChartMill assigns a fundamental rating of 2 / 10 to MYSZ.


What is the valuation status for MYSZ stock?

ChartMill assigns a valuation rating of 0 / 10 to MY SIZE INC (MYSZ). This can be considered as Overvalued.


How profitable is MY SIZE INC (MYSZ) stock?

MY SIZE INC (MYSZ) has a profitability rating of 0 / 10.


How financially healthy is MY SIZE INC?

The financial health rating of MY SIZE INC (MYSZ) is 3 / 10.


Can you provide the expected EPS growth for MYSZ stock?

The Earnings per Share (EPS) of MY SIZE INC (MYSZ) is expected to grow by 37.13% in the next year.